Target intelligence / Profile preview

Immunoglobulin lambda variable (VI)-25-1 (IGLVVI-25-1)

Target
IGLVVI-25-1
Molecular classification
Other (Immunoglobulin variable region pseudogene)
01

Overview

Immunoglobulin lambda variable (VI)-25-1 is designated as a pseudogene, meaning it resembles a functional immunoglobulin variable region gene but does not encode a functional immunoglobulin protein product[6][8]. The canonical full name and database entries reflect its similarity to immunoglobulin lambda variable region subgroup VI but with the “25-1” designation[6]. Functional immunoglobulin lambda variable region genes participate in antigen recognition as part of the antibody structure, but this pseudogene is not functionally expressed. As such, it is not considered a therapeutic target, receptor, or biomarker, and has no established disease association or safety profile. The presence of “variable” and “VI” in the name indicates its location and classification within immunoglobulin gene families, but its pseudogene status disqualifies it from biological or pharmacological relevance[6][8]. If you require information on therapeutic targets within the immunoglobulin lambda variable family, such as IGLV3-25 or other functional alleles, those are properly characterized as contributors to antigen binding and immune response[3][4][5], but IGLVVI-25-1 is not one of those due to its pseudogene nature.

Other names
IGLV(VI)-25-1lambdavg3

Beyond the preview

Go deeper on Immunoglobulin lambda variable (VI)-25-1 (IGLVVI-25-1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin lambda variable (VI)-25-1 (IGLVVI-25-1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call